Carvedilol in the treatment of elderly patients with chronic heart failure

Chronic heart failure (CHF) is common, and increases in incidence and prevalence with age. There are compelling data demonstrating reduced mortality and hospitalizations with adrenergic blockade in older patients with CHF. Despite this, many older patients remain under-treated. The aim of the presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Witte, Klaus KA, Clark, Andrew L
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2544370/
https://www.ncbi.nlm.nih.gov/pubmed/18488879
_version_ 1782159179959500800
author Witte, Klaus KA
Clark, Andrew L
author_facet Witte, Klaus KA
Clark, Andrew L
author_sort Witte, Klaus KA
collection PubMed
description Chronic heart failure (CHF) is common, and increases in incidence and prevalence with age. There are compelling data demonstrating reduced mortality and hospitalizations with adrenergic blockade in older patients with CHF. Despite this, many older patients remain under-treated. The aim of the present article is to review the potential mechanisms of the benefits of adrenergic blockade in CHF and the clinical data available from the large randomized studies, focusing particularly on older patients.
format Text
id pubmed-2544370
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-25443702009-05-20 Carvedilol in the treatment of elderly patients with chronic heart failure Witte, Klaus KA Clark, Andrew L Clin Interv Aging Review Chronic heart failure (CHF) is common, and increases in incidence and prevalence with age. There are compelling data demonstrating reduced mortality and hospitalizations with adrenergic blockade in older patients with CHF. Despite this, many older patients remain under-treated. The aim of the present article is to review the potential mechanisms of the benefits of adrenergic blockade in CHF and the clinical data available from the large randomized studies, focusing particularly on older patients. Dove Medical Press 2008-03 2008-03 /pmc/articles/PMC2544370/ /pubmed/18488879 Text en © 2008 Dove Medical Press Limited. All rights reserved
spellingShingle Review
Witte, Klaus KA
Clark, Andrew L
Carvedilol in the treatment of elderly patients with chronic heart failure
title Carvedilol in the treatment of elderly patients with chronic heart failure
title_full Carvedilol in the treatment of elderly patients with chronic heart failure
title_fullStr Carvedilol in the treatment of elderly patients with chronic heart failure
title_full_unstemmed Carvedilol in the treatment of elderly patients with chronic heart failure
title_short Carvedilol in the treatment of elderly patients with chronic heart failure
title_sort carvedilol in the treatment of elderly patients with chronic heart failure
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2544370/
https://www.ncbi.nlm.nih.gov/pubmed/18488879
work_keys_str_mv AT witteklauska carvedilolinthetreatmentofelderlypatientswithchronicheartfailure
AT clarkandrewl carvedilolinthetreatmentofelderlypatientswithchronicheartfailure

Ejemplares similares